Urologic Cancers
A urologic cancer diagnosis can be devastating. Our dedicated team of experts takes an integrated, patient-centered approach to diagnose and treat prostate, kidney, bladder and testicular cancer to ensure optimal outcomes with minimal impact on your quality of life. Contact us for a consultation.
As a National Cancer Institute-designated comprehensive cancer center, City of Hope’s urology and urologic oncology program is uniquely positioned to provide personalized and comprehensive treatment plans, along with access to groundbreaking clinical trials.
City of Hope is a nationally recognized leader in researching and treating urologic cancers.
Our Urologic Oncology Program Highlights:
- Advanced imaging technologies that can accurately pinpoint a tumor’s size, shape and location, enhancing our doctors’ detection and treatment planning capabilities, as well as better monitoring of “active surveillance” patients
- Minimally invasive and robotically assisted surgical techniques that can offer optimal outcomes with less pain, reduced scarring and faster healing time
- Targeted radiation regimens that are sculpted to the size and shape of the tumor, focusing its impact on cancer cells while minimizing exposure to nearby normal tissues
- A drug development pipeline that quickly identifies new cancer drugs and turns them into promising therapies for clinical trials
- Access to innovative clinical trials that target specific stages of the cancer spectrum Enhanced urinary diversion techniques that minimize interference with everyday life
- Leading expertise in complex surgery and reconstruction, including for pelvic floor dysfunction, resulting from cancer or treatment, that can diminish a patient's quality of life. During pelvic floor reconstruction surgery, City of Hope's leading-edge surgical teams use local tissue to restore the pelvic floor. Learn more about pelvic floor dysfunction and treatments.
Additionally, City of Hope patients have access to our extensive team of supportive care and survivorship experts, who will help you and your caregivers achieve and maintain a better quality of life during and after your urologic cancer treatment.
City of Hope is one of the few facilities designated a comprehensive cancer center by the National Cancer Institute.
Our developments in the areas of breakthrough cancer drugs, bone marrow transplants and CAR T cell therapy are recognized internationally.
Our leadership in research and innovation continually enhances our ability to provide novel and differentiated approaches to cancer care.
Pedram Aram, M.D., believes that doctors have the power to change lives. He is committed to making a positive impact on patients' lives by utilizing his expertise in benign/general urology, including treatment of prostate and testicular cancer, kidney cancer and transplant, and robotic-assisted and
Kevin Chan, M.D., is a urologic surgeon specializing in bladder cancer and surgical treatment of male urinary incontinence.
Seth Cohen, M.D., is a urologic surgeon with a focus on female pelvic medicine and reconstructive surgery at City of Hope's community practice sites in Orange County.
Kai Dallas, M.D., is an assistant clinical professor in the Department of Surgery at City of Hope.
Donald Hannoun, M.D., is a surgeon practicing urology and urologic oncology at City of Hope | Antelope Valley and Santa Clarita.
Michael Lao, M.D., is an assistant clinical professor practicing urology and urologic oncology at City of Hope in Antelope Valley and Santa Clarita.
Clayton Lau, M.D., is chief of the Division of Urology and Urologic Oncology and an expert in prostate cancer.
Emmanuel Mitsinikos, M.D., is a surgeon and assistant clinical professor in the Department of Surgery, Division of Urology and Urologic Oncology at City of Hope Upland.
Jeremy Montez, M.D., is a urologic surgeon at City of Hope's Glendora and West Covina locations.
Philip G. Pearson, M.D., is a urologic surgeon at City of Hope's community practice site in Pasadena, California.
Alexander Chehrazi-Raffle, M.D., is the assistant professor, department of Medical Oncology & Therapeutics Research.
Tanya Barauskas Dorff, M.D., is a medical oncologist and professor in the Department of Medical Oncology & Therapeutics Research.
Sumanta Kumar Pal, M.D., FASCO, is an internationally recognized leader in the area of genitourinary cancers. He is the co-director of City of Hope's Kidney Cancer Program and is the head of the kidney and bladder cancer disease team at the institution.
Abhishek Tripathi, M.D., associate professor, Department of Medical Oncology & Therapeutics Research.
Debra Wong, M.D., is an a medical oncologist in the Department of Medical Oncology & Therapeutics Research at City of Hope.
Savita Dandapani, M.D., Ph.D., is a radiation oncologist at City of Hope who specializes in improving treatment outcomes and reducing side effects for cancer patients undergoing radiation therapy.
Scott Glaser, M.D., is a radiation oncologist and an assistant professor of radiation oncology at City of Hope.
Garth Green, M.D., brings nearly 25 years of radiation oncology experience to City of Hope South Bay.
Specializing in radiation oncology, Paul Mandelin, D.O., is a board certified radiation oncologist at City of Hope's Corona location.
Jeffrey Wong, M.D., is renowned for his efforts in targeted therapy using image-guided/intensity modulated radiotherapy, recently applying this approach to bone marrow transplantation.
Ravindra Kumar Guruswamy, M.D., M.P.H., is a urologic surgeon specializing in bladder cancer and surgical treatment.
